Patient-Reported Outcome Measures for Patients With CKD: The Case for Patient-Reported Outcomes Measurement Information System (PROMIS) Tools

被引:3
作者
Tang, Evan [1 ,2 ]
Yantsis, Alyssa [1 ,2 ]
Ho, Matthew [2 ]
Hussain, Junayd [2 ]
Dano, Sumaya [1 ,2 ]
Aiyegbusi, Olalekan L. [3 ,4 ]
Peipert, John D. [5 ]
Mucsi, Istvan [1 ,2 ]
机构
[1] Univ Toronto, Temerty Fac Med, 585 Univ Ave,MARS Bldg,Floor 9,Room 9062, Toronto, ON M5G 2N2, Canada
[2] Univ Hlth Network, Ajmera Transplant Ctr, Toronto, ON, Canada
[3] Univ Birmingham, Inst Appl Hlth Res, Ctr Patient Reported Outcomes Res, Birmingham, England
[4] Natl Inst Hlth Res Appl Res Ctr West Midlands, Birmingham, England
[5] Northwestern Univ, Dept Med Social Sci, Chicago, IL USA
基金
美国国家卫生研究院;
关键词
PHYSICAL FUNCTION; DEPRESSIVE SYMPTOMS; RESPONSE BURDEN; SHORT-FORMS; CARE; TRANSPLANTATION; PROFILES; PROGRESS; DISEASE; LINKING;
D O I
10.1053/j.ajkd.2023.09.007
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Chronic kidney disease (CKD), kidney failure, and kidney replacement therapies are associated with high symptom burden and impaired health -related quality of life (HRQOL). Symptoms change with disease progression or transition between treatment modalities and frequently go unreported and unmanaged. Tools that reliably monitor symptoms may improve the management of patients with CKD. Patient -reported outcome measures (PROMs) assess symptom severity; physical, psychological, social, and cognitive functioning; treatment -related side effects; and HRQOL. Systematic use of PROMs can improve patient-provider communication, patient satisfaction, clinical outcomes, and HRQOL. Potential barriers to their use include a lack of engagement, response burden, and limited guidance about PROM collection, score interpretation, and work fl ow integration. Well-de fi ned, acceptable, and effective clinical response pathways are essential for implementing PROMs. PROMs developed by the Patient -Reported Outcomes Measurement Information System (PROMIS) address some challenges and may be suitable for clinical use among patients with CKD. PROMIS tools assess multiple patientvalued, clinically actionable symptoms and functions. They can be administered as fi xed -length, customized short forms or computer adaptive tests, offering precise measurement across a range of symptom severities or function levels, tailored questions to individuals, and reduced question burden. Here we provide an overview of the potential use of PROMs in CKD care, with a focus on PROMIS.
引用
收藏
页码:508 / 518
页数:11
相关论文
共 77 条
  • [1] Key considerations to reduce or address respondent burden in patient-reported outcome (PRO) data collection
    Aiyegbusi, Olalekan Lee
    Roydhouse, Jessica
    Rivera, Samantha Cruz
    Kamudoni, Paul
    Schache, Peter
    Wilson, Roger
    Stephens, Richard
    Calvert, Melanie
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [2] A narrative review of current evidence supporting the implementation of electronic patient-reported outcome measures in the management of chronic diseases
    Aiyegbusi, Olalekan Lee
    Nair, Devika
    Peipert, John Devin
    Schick-Makaroff, Kara
    Mucsi, Istvan
    [J]. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021, 12
  • [3] Patient and clinician opinions of patient reported outcome measures (PROMs) in the management of patients with rare diseases: a qualitative study
    Aiyegbusi, Olalekan Lee
    Isa, Fatima
    Kyte, Derek
    Pankhurst, Tanya
    Kerecuk, Larissa
    Ferguson, James
    Lipkin, Graham
    Calvert, Melanie
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2020, 18 (01)
  • [4] Patient and Clinician Perspectives on Electronic Patient-Reported Outcome Measures in the Management of Advanced CKD: A Qualitative Study
    Aiyegbusi, Olalekan Lee
    Kyte, Derek
    Cockwell, Paul
    Marshall, Tom
    Dutton, Mary
    Walmsley-Allen, Natalie
    Slade, Anita
    McMullan, Christel
    Calvert, Melanie
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 74 (02) : 167 - 178
  • [5] Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: A systematic review
    Aiyegbusi, Olalekan Lee
    Kyte, Derek
    Cockwell, Paul
    Marshall, Tom
    Gheorghe, Adrian
    Keeley, Thomas
    Slade, Anita
    Calvert, Melanie
    [J]. PLOS ONE, 2017, 12 (06):
  • [6] Selection of patient-reported outcome measures (PROMs) for use in health systems
    Al Sayah, Fatima
    Jin, Xuejing
    Johnson, Jeffrey A.
    [J]. JOURNAL OF PATIENT-REPORTED OUTCOMES, 2021, 5 (SUPPL 2)
  • [7] Using patient-reported outcome measures (PROMs) to promote quality of care in the management of patients with established kidney disease requiring treatment with haemodialysis in the UK (PROM-HD): a qualitative study protocol
    Anderson, Nicola Elzabeth
    Calvert, Melanie
    Cockwell, Paul
    Dutton, Mary
    Aiyegbusi, Olalekan Lee
    Kyte, Derek
    [J]. BMJ OPEN, 2018, 8 (10):
  • [8] Perceptions of Response Burden Associated with Completion of Patient-Reported Outcome Assessments in Oncology
    Atkinson, Thomas M.
    Schwartz, Carolyn E.
    Goldstein, Leah
    Garcia, Iliana
    Storfer, Daniel F.
    Li, Yuelin
    Zhang, Jie
    Bochner, Bernard H.
    Rapkin, Bruce D.
    [J]. VALUE IN HEALTH, 2019, 22 (02) : 225 - 230
  • [9] Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
    Basch, Ethan
    Deal, Allison M.
    Dueck, Amylou C.
    Scher, Howard I.
    Kris, Mark G.
    Hudis, Clifford
    Schrag, Deborah
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (02): : 197 - 198
  • [10] Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
    Basch, Ethan
    Deal, Allison M.
    Kris, Mark G.
    Scher, Howard I.
    Hudis, Clifford A.
    Sabbatini, Paul
    Rogak, Lauren
    Bennett, Antonia V.
    Dueck, Amylou C.
    Atkinson, Thomas M.
    Chou, Joanne F.
    Dulko, Dorothy
    Sit, Laura
    Barz, Allison
    Novotny, Paul
    Fruscione, Michael
    Sloan, Jeff A.
    Schrag, Deborah
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (06) : 557 - +